FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer

The tyrosine kinase receptor, HER2 is a crucial prognostic marker and therapeutic target for breast cancer; however, the downstream targets and biological effectors of HER2 remain unclear. We investigated the relationship between HER2 and the transcription factor FoxM1 in breast cancer. HER2 and Fox...

Full description

Saved in:
Bibliographic Details
Main Authors: Francis, Richard E., Myatt, Stephen S., Krol, Janna, Hartman, Johan, Peck, Barrie, McGovern, Ursula B., Wang, Jun, Guest, Stephanie K., Filipovic, Aleksandra, Gojis, Ondrej, Palmieri, Carlo, Peston, David, Shousha, Sami, Yu, Qunyan, Sicinski, Piotr, Coombes, R. Charles, Lam, Eric W.-F.
Format: Artigo
Language:Inglês
Published: 2009
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3065068/
https://ncbi.nlm.nih.gov/pubmed/19513552
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items